<h1>Jenburkt Pharmaceuticals Shifts Registered Office within Mumbai Local Limits</h1>
Jenburkt Pharmaceuticals Ltd has announced the relocation of its registered office, a move approved by the company's Board of Directors. The shift is scheduled to take effect from July 21, 2026.
The decision follows a resolution passed by the Board of Directors on July 13, 2026, to move the company’s base within the local limits of Mumbai.
The transition involves moving from the previous location at Nirmala Apartments, 93, Jay Prakash Road, Andheri West, Mumbai 400 058. The new registered office will be located at 14th floor, Unicorn, Dattaji Salvi Marg, off Veera Desai Road, Andheri West, Mumbai- 400 053.
The company stated that there is no change in the jurisdiction of the Registrar of Companies (ROC). Furthermore, all other operational details such as the telephone number, email address, and website address remain unchanged following the relocation.
Stock Price Movement
Jenburkt Pharmaceuticals Ltd closed the trading day on Monday, having fallen 1.15% to settle at ₹1101.80. Shares experienced volatility throughout the session, trading within an intraday range from a low of ₹1100.00 to a peak of ₹1120.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.